NEWS CENTER

United in Purpose, Winning the Battle in 2026 | Keyuan Group Holds First-Quarter Kickoff and Second-Quarter Pledge Rally

Publish Time:

2026-04-08

With the vigorous spring breeze ushering in a new journey, we are uniting our hearts and pooling our strengths to tackle the toughest challenges once again. On April 8, Keyuan Group (Keyuan Pharmaceutical, stock code 301281.SZ; Linuo Pharmaceutical) solemnly convened the “First-Quarter Strong Start and Second-Quarter Mobilization Conference.” Chairman Li Hongfu, President Wei Zhiguo, other members of the management team, heads of all business units and regional divisions within the Marketing Center, as well as representatives from relevant functional departments, gathered to conduct a comprehensive review of the first-quarter marketing performance, outline the key tasks for the second quarter and the full year, and sound the rallying call for an all-out sprint toward achieving the year’s targets.

With the vigorous spring breeze ushering in a new journey, we are uniting our hearts and pooling our strengths to tackle the toughest challenges once again. On April 8, Keyuan Group (Keyuan Pharmaceutical, stock code 301281.SZ; Linuo Pharmaceutical) solemnly convened the “First-Quarter Strong Start and Second-Quarter Mobilization Conference.” Chairman Li Hongfu, President Wei Zhiguo, other senior management leaders, heads of all business units and regional divisions within the Marketing Center, as well as representatives from relevant functional departments, gathered to conduct a comprehensive review of the first-quarter marketing performance, outline the key tasks for the second quarter and the full year, and sound the rallying call for an all-out sprint toward achieving the year’s targets.

Clear Strategic Direction, Strong Start in the First Quarter

The conference officially commenced with the rousing “Liluo Anthem” and a recitation of the company’s corporate culture. The meeting provided a comprehensive review of the first-quarter performance across all areas of work, highlighting that the Group’s overall operations remained stable and well-organized, with seamless synergy among its various business units. Both the API segment and the marketing system maintained strong growth momentum, laying a solid foundation for the successful achievement of the annual strategic objectives.

During the meeting, business units—including various centers, business divisions, and branch offices—presented their work reports in turn, focusing on benchmarking against customers and competitors, breaking down and implementing subsequent quarterly plans, clarifying objectives, assigning clear responsibilities, and ensuring the precise advancement of all tasks.

In his strategic deployment address, Chairman Li Hongfu emphasized that the Group’s strong start in the first quarter was attributable to the transformation of its marketing model, the optimization of its management mechanisms, and precise cost control. The Company will steadfastly advance its core strategy of integrated API–formulation operations, continuously strengthen its industrial foundation, leverage the advantages of its listed-company platform, accelerate the development of high-growth product segments, and seize the opportunities presented by the industry’s transformation and upgrading.

Anchor New Goals, Secure Victory in the Second Quarter

The meeting emphasized that the Group must adhere to the “1+2” strategy as its overarching guiding principle, maintain stable overall performance while pursuing long-term development, strengthen synergistic, high-quality development between raw materials and finished formulations, accelerate product portfolio optimization, and make all-out efforts to achieve the annual business targets.

President Wei Zhiguo, Executive Vice President Li Lei, and other leaders delivered concluding remarks and directives, emphasizing that all marketing personnel must stay firmly focused on the set objectives, rigorously execute plans, and strengthen cross-departmental collaboration. They urged everyone to approach their work with greater confidence, a more pragmatic attitude, and more efficient action, leaving no stone unturned in the decisive battle for the second quarter.

Recognizing Role Models, Ushering in a New Journey

Concurrently with the conference, a ceremony was held to recognize outstanding performance in the first quarter, during which numerous awards were solemnly presented, including the Model Performer Award, the Outstanding Individual Award, the Excellence in Support Award, the Market Development Pioneer Award, and the Outstanding Contribution Award. These honors recognized a group of benchmark performers and exceptional support teams, leveraging their exemplary achievements to inspire and energize all employees to strive for greater success.

This conference serves not only as a review of our first-quarter performance but also as a rallying call to press ahead in the second quarter and a mobilization drive to achieve our year-long objectives. As we embark on this new journey, all colleagues at Keyuan Group will draw inspiration from our strong start to the year, unite in purpose and forge ahead with courage and determination, delivering outstanding results to secure victory in 2026 and boldly write a new chapter of high-quality development for the Group!

Keyuan Pharmaceutical Makes Its Debut at the 2026 European Cosmetics Ingredients Exhibition: “Active Pharmaceutical Ingredients +” Empowers the Global Beauty Industry with a Diversified Ecosystem

Deepening Cooperation and Jointly Pioneering a New Journey: L’Oréal Group Delegation Visits Keyuan Pharmaceutical for Inspection and Exchange

Keyuan Pharmaceutical Makes Its Debut at the 2026 European Cosmetics Ingredients Exhibition: “Active Pharmaceutical Ingredients +” Empowers the Global Beauty Industry with a Diversified Ecosystem

Deepening Cooperation and Jointly Pioneering a New Journey: L’Oréal Group Delegation Visits Keyuan Pharmaceutical for Inspection and Exchange